Atlas Trials

Safety and Tolerability of SHR-1918 in Healthy Subjects

Clinical trial NCT05432544 · UNKNOWN

Trial details

NCT number
NCT05432544
Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperlipemia
Start date
2022-06-27
Primary completion
2023-12-11
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.